Bid Publish Date
13-Dec-2024, 12:06 pm
Bid End Date
04-Jan-2025, 12:00 pm
Location
Progress
Quantity
4622
Category
Protein supplement 500gm Jar
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army Diemethyl Fumarate 240mg Delayed Release with granules cap, Protein supplement 500gm Jar, Tobramycin 0. 3percent Fluromethalone 0. 1percent Opthalmic Solneye Drop, Rosuvastatin 10mg Tab, Eye Drop Natamycin 5percent, Eye drop Voriconazole 1percent in CENTRAL DELHI, DELHI. Quantity: 4622 issued by. Submission Deadline: 04-01-2025 12: 00: 00. View full details and respond.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Diemethyl Fumarate 240mg Delayed Release with granules cap , Protein supplement 500gm Jar , Tobramycin 0.3percent Fluromethalone 0.1percent Opthalmic Solneye Drop , Rosuvastatin 10mg Tab , Eye Drop Natamycin 5percent , Eye drop Voriconazole 1percent
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Diemethyl Fumarate 240mg Delayed Release with granules cap
Diemethyl Fumarate 240mg Delayed Release with granules cap
Protein supplement 500gm Jar
Protein supplement 500gm Jar
Tobramycin 0.3percent Fluromethalone 0.1percent Opthalmic Solneye Drop
Tobramycin 0.3% & Fluromethalone 0.1% Opthalmic Solneye Drop
Rosuvastatin 10mg Tab
Rosuvastatin 10mg Tab
Eye Drop Natamycin 5percent
Eye Drop Natamycin 5%
Eye drop Voriconazole 1percent
Eye drop Voriconazole 1%
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Diemethyl Fumarate 240mg Delayed Release with granules cap | Diemethyl Fumarate 240mg Delayed Release with granules cap | 672 | no | [email protected] | 15 | |
| 2 | Protein supplement 500gm Jar | Protein supplement 500gm Jar | 600 | jar | [email protected] | 15 | |
| 3 | Tobramycin 0.3percent Fluromethalone 0.1percent Opthalmic Solneye Drop | Tobramycin 0.3% & Fluromethalone 0.1% Opthalmic Solneye Drop | 300 | bott | [email protected] | 15 | |
| 4 | Rosuvastatin 10mg Tab | Rosuvastatin 10mg Tab | 3,000 | no | [email protected] | 15 | |
| 5 | Eye Drop Natamycin 5percent | Eye Drop Natamycin 5% | 30 | bott | [email protected] | 15 | |
| 6 | Eye drop Voriconazole 1percent | Eye drop Voriconazole 1% | 20 | bott | [email protected] | 15 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
07-Jan-2025, 10:00 am
Opening Date
07-Jan-2025, 10:30 am
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | DIVIT NUTRACEUTICALS PRIVATE LIMITED Under PMA | - | 16-12-2024 17:47:22 | |
| 2 | JAIN PHARMA Under PMA | - | 03-01-2025 23:24:41 | |
| 3 | NUTRAKEM INDIA PRIVATE LIMITED Under PMA | - | 01-01-2025 18:48:27 | |
| 4 | REKIN PHARMA PRIVATE LIMITED Under PMA | - | 01-01-2025 21:26:24 | |
| 5 | SHRISHTI PHARMACEUTICAL & SURGICALS Under PMA | - | 03-01-2025 19:40:09 | |
| 6 | SUNIL PHARMACY Under PMA | - | 03-01-2025 20:23:00 | |
| 7 | VANDANA MEDICO TRADERS Under PMA | - | 06-01-2025 13:24:07 |
Key insights about DELHI tender market
The eligibility requirements include being a registered entity, and the bidder or its OEM must have at least 3 years of relevant experience in manufacturing and supplying similar products to government entities.
Bidders must submit:
The registration process involves submitting the necessary documentation via the GeM portal, ensuring that all criteria stipulated in the tender documentation are met.
Only digitally signed documents in PDF and Excel formats are accepted for submission through the GeM platform, following the guidelines in the user manual.
The technical specifications are listed in detail within the provided BoQ document; bidders must refer to this document for each product’s specific requirements.
Products must conform to the standards established by the Indian Pharmacopoeia and must be tested for compliance prior to delivery.
Bidders must demonstrate compliance with the BOQ specifications, submit all required certifications, and adhere to local content regulations as per the Make in India policy.
Bidders are required to submit an EMD as per the regulations stated in the tender document, which is a prerequisite for participating in the bid.
A performance bank guarantee (PBG) may be required post tender acceptance to ensure compliance with the terms of supply.
Payment terms are generally structured around delivery milestones and may require provision of an invoice after delivery and acceptance of goods.
Bidders must adhere to the submission deadlines and bid opening dates as specified in the tender documentation.
The evaluation process will be based on an item-wise analysis, with the selection of the lowest qualified bid in each schedule.
Results will be communicated through the GeM platform following the completion of the evaluation process, with notification to the successful bidders.
While this tender does not offer specific exemptions for experience criteria for MSEs, they are encouraged to participate and must adhere to standard requirements.
There are no exemptions specified for startups in terms of experience or turnover for this particular tender.
The tender mandates a minimum local content requirement for qualifying bidders, thus aligning with the Make in India initiative and promoting local manufacturing.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS